Press release
Orthofix to Report Third Quarter 2024 Financial Results
Company to Host Conference Call on Thursday, November 7, 2024 at 8:30 am ET LEWISVILLE, Texas--(BUSINESS WIRE)-- Orthofix Medical Inc. (NASDAQ:OFIX), a

About this update from Orthofix Medical Inc.
Company to Host Conference Call on Thursday, November 7, 2024 at 8:30 am ET LEWISVILLE, Texas --(BUSINESS WIRE)-- Orthofix Medical Inc . (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its third quarter 2024 financial results on Thursday, November 7, 2024 before market open. The Company will host a conference call and webcast to review results at 8:30 am ET the same day. Interested parties may access the conference call by dialing (888) 330-2508 in the U.S. , and (240) 789-2735 in all other locations, and referencing the event passcode 9556380. A replay of the call will be available for three weeks by dialing (800) 770-2030 in the U.S. , and (647) 362-9199 in all other locations, and entering the event passcode 9556380. A webcast of the conference call and a copy of the release may be accessed at ir.Orthofix.com . Internet Posting of Information Orthofix routinely posts information that may be important to investors in the “Investor Relations” section of its website at www.orthofix.com . The Company encourages investors and potential investors to consult the Orthofix website regularly for important information about Orthofix . About Orthofix Orthofix is a global medical technology company headquartered in Lewisville, Texas . By providing medical technologies that heal musculoskeletal pathologies, we deliver exceptional experiences and life-changing solutions to patients around the world. Orthofix offers a comprehensive portfolio of spinal hardware, bone growth therapies, specialized orthopedic solutions, biologics and enabling technologies, including the 7D FLASH™ navigation system. To learn more, visit Orthofix.com and follow on LinkedIn . View source version on businesswire.com : https://www.businesswire.com/news/home/20241010350334/en/ Investor Relations Julie Dewey [email protected] 209.613.6945 Media Relations Denise Landry [email protected] 214.937.2529 Source: Orthofix Medical Inc.
View stock analysis, news, and events for Orthofix Medical Inc.